Sign In
Buy CATB
$3.36
+0.195 (+6.16%)
At Close: May 27, 2022
Gilead Sciences (GILD) Receives a Buy from Oppenheimer
07:56pm, Monday, 13'th Apr 2020
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Gilead Sciences (GILD) today. The company's shares closed last Monday at $75.08. According to
Gilead Sciences (GILD) Receives a Buy from Oppenheimer
07:56pm, Monday, 13'th Apr 2020
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Gilead Sciences (GILD – Research Report) today. The company’s shares closed
The three documents every South African abroad must have
12:36pm, Monday, 13'th Apr 2020
(Partner Content) Aside from the obvious things like your ID, hand sanitiser and some in-flight entertainment of course, these are essential travel items.
UAE reports 387 new Covid-19 cases, DHA to begin blood plasma treatments this week
08:05am, Monday, 13'th Apr 2020
It also announced two deaths, thereby raising the total number of fatalities as a result of this coronavirus in the UAE to 22
Dubai to use recovered coronavirus patients’ plasma to treat critical COVID-19 cases
07:58pm, Sunday, 12'th Apr 2020
Dubai’s health authority (DHA) said on Sunday it will start this week treating critical coronavirus
Intercept Pharma (ICPT) Gets a Buy Rating from Wedbush
05:31am, Sunday, 12'th Apr 2020
In a report issued on April 10, Liana Moussatos from Wedbush maintained a Buy rating on Intercept Pharma (ICPT –
